Shalini Sharp
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $484,548 | $2,605,521 |
| 2018 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $470,435 | $2,060,787 |
| 2017 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $455,785 | $2,642,719 |
Earnings-call appearances
-
Ultragenyx Pharmaceutical Inc. Q3 FY2020 Earnings Call2020-10-27
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q2 FY2020 Earnings Call2020-07-30
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q1 FY2020 Earnings Call2020-05-06
Ultragenyx Pharmaceutical Inc. (RARE)